financetom
Business
financetom
/
Business
/
Investors Increasingly Interested in Nutrien, RBC Capital Markets Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors Increasingly Interested in Nutrien, RBC Capital Markets Says
Aug 19, 2024 8:04 AM

10:55 AM EDT, 08/19/2024 (MT Newswires) -- Investors are increasingly interested in Nutrien ( NTR ) , with its shares "potentially bottoming" and "already pricing in downside scenarios, but also lacking obvious immediate catalysts", RBC Capital Markets said in a note over the weekend.

RBC sees investors looking for a turnaround in Nutrien's ( NTR ) Brazil Retail segment, confirmation points for Retail path to 2026 targets, confidence in potash stabilization, and excess cash generation for buybacks at depressed valuations.

In RBC's view, fertilizer equities "continue mixed as fertilizer prices stay within a relatively narrow range". It noted nitrogen "continues to tread along seasonal lows that are above the bank's prior expectations due to strengthening international natural gas prices". It also noted phosphate "remains tight", with a large India/OCP settlement further confirming global prices above $600/tonne, "but affordability remains a challenge". Lastly potash "continues to trade sideways, with the best affordability among the three nutrients, but also the best availability limiting price traction."

Nutrien's ( NTR ) share price was up 2.1% at last look on the TSX.

Price: 65.35, Change: +1.29, Percent Change: +2.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Sep 11, 2025
09:12 AM EDT, 09/11/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) said Thursday that its partner, Johnson & Johnson ( JNJ ) , has submitted an application to the European Medicines Agency seeking approval of icotrokinra to treat moderate-to-severe plaque psoriasis in adults and adolescents above 12 years of age. The investigational oral tablet selectively blocks the IL-23 receptor,...
Sector Update: Consumer Stocks Advance Premarket Thursday
Sector Update: Consumer Stocks Advance Premarket Thursday
Sep 11, 2025
09:14 AM EDT, 09/11/2025 (MT Newswires) -- Consumer stocks were advancing premarket Thursday, with the Consumer Discretionary Select Sector SPDR Fund ( XLY ) up 0.3% and the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.1% higher. Alibaba Group ( BABA ) shares were up 3.1% after the company said it priced a $3.2 billion offering of zero...
T. Rowe Price Group August Assets Under Management Rise Month Over Month
T. Rowe Price Group August Assets Under Management Rise Month Over Month
Sep 11, 2025
09:13 AM EDT, 09/11/2025 (MT Newswires) -- T. Rowe Price ( TROW ) reported preliminary assets under management Thursday of $1.729 trillion as of Aug 31, up from $1.703 trillion in the previous month. The company said its equity assets rose to $867 billion at the end of August from $859 billion as of July 31, and multi-assets increased to...
XPEL Acquires Assets of Chinese Distributor
XPEL Acquires Assets of Chinese Distributor
Sep 11, 2025
09:09 AM EDT, 09/11/2025 (MT Newswires) -- XPEL ( XPEL ) said Thursday it has acquired the assets of its exclusive distributor in China aftermarket. Financial terms of the transaction were not disclosed. The transaction structure will result in XPEL ( XPEL ) owning a 76% interest in the Chinese entity conducting business in China. The company said the purchase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved